PICC Capital Investment Management

UNISOC is a fabless semiconductor company specializing in the research and development of core chipsets for mobile communications and the Internet of Things (IoT). The company produces a wide range of products, including mobile chipset platforms that support various communication standards such as 2G, 3G, and 4G, as well as RF chipsets, wireless connection chipsets, security chipsets, TV chipsets, and image sensor chipsets. With a global workforce of over 4,500 employees and numerous research and development centers, UNISOC ranks among the top three suppliers of mobile baseband chipsets worldwide and is the largest pan-chip supplier in China. The company's offerings enable access to advanced technologies, including 5G and artificial intelligence, for consumer and industrial electronics.

Desino was founded in 1996 and is headquartered in Shanghai Zhangjiang Hi-Tech Park. The company's anti-AIDS drugs and anti-malarial drugs are the core development areas for the global public health crisis, and are committed to the development, production, registration and global sales of high-quality drugs.The Dyson Company R&D Center is located in Shanghai and is the National Enterprise Technology Center, the National Anti-AIDS Drug Engineering Technology Research Center and the National Postdoctoral Research Station.

Asia Pacific Medical Group operates a network of hospitals across Southeast Asia, focusing on both local and international patients. The group provides a comprehensive range of medical services, including neurology, oncology, cardiovascular medicine, pediatrics, dermatology, neurosurgery, plastic surgery, and tumor treatment therapies. Their facilities are designed to deliver inpatient healthcare services while ensuring affordability for patients seeking treatment. By offering specialized services such as gamma-knife treatment and cosmetology, Asia Pacific Medical Group aims to address various healthcare needs and enhance the quality of care available in the region.

Atech Automotive Electronics products are based on the generation of electronic and electrical architecture and the SOA concept and develop central core domain control, body controllers, domain controllers, Ethernet gateways, and radio frequency bluetooth. It is a company that designs, develops, manufactures, and sells automotive electronic products.

GAC Aion New Energy Automobile is a manufacturer of electric vehicles and offers new energy products and services. It is a Chinese electric vehicle marque of Guangzhou Automobile Corporation. The company was established in 2017 and was introduced in 2018 as a sub-brand and in 2020 as a marque.

Shanghai InGeek Cyber Security Co., Ltd, founded in 2002 and headquartered in Shanghai, China, specializes in information, network, and system security services. As a subsidiary of Shanghai Yinji Information Technology Co., Ltd, InGeek focuses on consulting, implementation, operation, maintenance, and software development related to cybersecurity. The company is committed to enhancing Internet of Things (IoT) security and provides industry-specific network information security products and comprehensive security solutions primarily for the communications, financial, and automotive sectors. InGeek aims to create a safer and smarter environment for connected vehicles, promoting innovation in technology while ensuring robust protection against cyber threats.

Jitai Medicine (METiS) is a biotechnology company that uses artificial intelligence to drive drug delivery and drug discovery. It combines advanced technologies like artificial intelligence, machine learning, and quantum simulation to achieve more effective design of innovative delivery materials, drug candidate selection and formulation design, "programmable nucleic acid drug" development, and nucleic acid delivery design.

METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

ChangXin Memory Technologies focuses on the development and manufacture of dynamic random-access memory (DRAM) semiconductor products. The company specializes in integrated circuits designed for data memory and related functions, emphasizing low-power data storage solutions. Its activities encompass research and development, design, production, and sales of these integrated circuits, catering to various industry users.

Tongxin makes magnetically-suspended artificial blood pumps which are designed to replace the human heart. They are undergoing clinical trials in China after being fast-tracked through the approval process by the National Medical Products Administration, state-run Xinhua News Agency

NeoCura is a biotechnology company based in Shenzhen, China, founded in 2017. It specializes in developing artificial intelligence-based platforms and diagnostic tests aimed at improving cancer treatment and diagnosis. The company's key offerings include NeoCura AI ALPINE, which predicts tumor neoantigen candidates; NeoCura AI EVEREST, designed for validating these neoantigens to enhance patient outcomes; NeoCura TP, an intelligent companion diagnostics tool that forecasts treatment options for immunotherapy; and NeoCura Ag, an AI-enabled immunotherapy that targets patient-specific neoantigens. Additionally, NeoCura provides diagnostic and medical laboratory services, leveraging AI to collect and analyze molecular biology and clinical data for better decision-making by healthcare professionals.

Vastai Technologies specializes in the development of semiconductor chips tailored for computer vision, video processing, and various artificial intelligence applications. The company's innovative products are designed to enhance computing power for AI visual tasks, allowing manufacturers of computer devices to integrate advanced chip technology into their offerings. By focusing on the optimization of AI capabilities, Vastai Technologies aims to support the growing demand for efficient and powerful processing solutions in the tech industry.

Weishi Energy is a hydrogen fuel cell product research and development manufacturer, focusing on the market operation of hydrogen fuel cell technology, and is committed to promoting the low-carbon sustainable development of human energy. It is mainly engaged in the research and development, production and sales of hydrogen fuel cell products. At present, Weishi Energy has deployed five R&D centers in Shanghai, Baoding, Japan, Germany, and Canada. It has established a culturally diverse and technologically advanced R&D team, and strictly follows the V model development process to create vehicle-level fuel cell power systems and components. The company's main products include fuel cell engines, electric stacks, 35MPa/70MPa on-board hydrogen systems, bottle valves and pressure reducing valves, etc.

SVOLT manufacturer of electric batteries. They specialize in the manufacturing of automotive power batteries and energy storage systems. Their market applications include passenger cars, commercial vehicles, energy storage, and light power solutions. Their products include batteries and energy storage batterie. They provide users with energy vehicle charging piles, batteries recycling, and solutions.

Jitai Medicine (METiS) is a biotechnology company that uses artificial intelligence to drive drug delivery and drug discovery. It combines advanced technologies like artificial intelligence, machine learning, and quantum simulation to achieve more effective design of innovative delivery materials, drug candidate selection and formulation design, "programmable nucleic acid drug" development, and nucleic acid delivery design.

Ningbo Jenscare Scientific develops solutions around structural heart disease that include the treatment of the tricuspid valve, mitral valve, aortic valve, and heart failure. The company's contact information is its physical address.

GeneQuantum Healthcare (Suzhou) Co., Ltd. is a high-tech company specializing in the research and development of innovative biotherapeutics, particularly in the field of anti-tumor therapies. Founded in August 2013 in Suzhou Industrial Park, the company has established a world-class bio-conjugation technology platform that utilizes a ligase-dependent conjugation method. This advanced technology significantly enhances the therapeutic window for developing a series of next-generation Antibody-Drug-Conjugates (ADCs). GeneQuantum is actively working on advancing its ADC candidates towards Investigational New Drug (IND) applications in both the United States and China, while also focusing on expanding its product pipeline to address unmet medical needs in cancer treatment.

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

XtalPi Inc. is a pharmaceutical technology company based in Cambridge, Massachusetts, with additional offices in China. Founded in 2014 by a team of quantum physicists from MIT, XtalPi focuses on transforming drug research and development through its Intelligent Digital Drug Discovery and Development (ID4) platform. This platform integrates quantum mechanics, artificial intelligence, and high-performance cloud computing to enhance the efficiency and accuracy of drug R&D processes. XtalPi's offerings include advanced tools for crystal structure prediction and determination, solid state testing, small molecule drug design, and AI model development. The company aims to accelerate drug discovery and development, thereby contributing to global health improvements. Its innovative technologies have garnered recognition within the industry and facilitated strategic partnerships with leading pharmaceutical companies.

Yijia follows the development model of "integration of medical care, health care, and health care," draws lessons from the mainstream model of mature compound health services in developed countries, implements the concept of "health care for every Chinese family," and focuses on professional medical-level services, nursing, rehabilitation, and elderly care, integrating diverse resources, and providing high-quality care.

MLog Tianqijia is based in Wuhan, China, and operates a commercial weather service platform. The company leverages meteorological forecast technology and big data to deliver a range of meteorological services to its users. By integrating advanced forecasting techniques with data analytics, MLog Tianqijia aims to provide accurate and timely weather information to meet the needs of various stakeholders.

New Flow Technology is a big data company focused on serving the financial industry. It offers a data-as-a-service platform that includes the DRCP data risk control platform. This technology enables banks, insurance companies, and other financial institutions to access accurate data, which facilitates improved strategic decision-making. By providing reliable data solutions, New Flow Technology aims to enhance operational efficiency and risk management for its clients.